TY - JOUR
T1 - Killed whole-cell oral cholera vaccine induces CCL20 secretion by human intestinal epithelial cells in the presence of the short-chain fatty acid, butyrate
AU - Sim, Ju Ri
AU - Kang, Seok Seong
AU - Lee, Daesang
AU - Yun, Cheol Heui
AU - Han, Seung Hyun
N1 - Publisher Copyright:
© 2018 Sim, Kang, Lee, Yun and Han.
PY - 2018/1/29
Y1 - 2018/1/29
N2 - Short-chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, modulate immune responses in the gut. However, the effect of SCFAs on mucosal vaccine-induced immune cell migration is poorly understood. Here, we investigated whether SCFAs modulate chemokine expression induced by the killed whole-cell oral cholera vaccine, ShancholTM, in human intestinal epithelial cells. ShancholTM induced expression of CCL2, CCL5, CCL20, and CXCL10 at the mRNA level, but not at the protein level. Interestingly, CCL20 secretion was substantially increased by co-stimulation with ShancholTM and butyrate, while neither acetate nor propionate showed such effect. Enhanced CCL20 secretion was associated with GPR109A activation, and histone deacetylase (HDAC) inhibition. In addition, co-treatment with ShancholTM and butyrate synergistically increased the secretion of adenosine triphosphate (ATP). Moreover, CCL20 secretion was decreased by inhibiting the extracellular ATP receptor P2X7. However, neither inflammasomes nor caspases were involved in CCL20 production. The culture supernatant of cells treated with ShancholTM and butyrate augmented human immature dendritic cell migration. Collectively, these results suggest that butyrate enhances ShancholTM-induced CCL20 production in human intestinal epithelial cells via HDAC inhibition and ATP-P2X7 signaling by activating GPR109A. These effects potentially enhance the mucosal immune responses in the gut induced by this oral cholera vaccine.
AB - Short-chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, modulate immune responses in the gut. However, the effect of SCFAs on mucosal vaccine-induced immune cell migration is poorly understood. Here, we investigated whether SCFAs modulate chemokine expression induced by the killed whole-cell oral cholera vaccine, ShancholTM, in human intestinal epithelial cells. ShancholTM induced expression of CCL2, CCL5, CCL20, and CXCL10 at the mRNA level, but not at the protein level. Interestingly, CCL20 secretion was substantially increased by co-stimulation with ShancholTM and butyrate, while neither acetate nor propionate showed such effect. Enhanced CCL20 secretion was associated with GPR109A activation, and histone deacetylase (HDAC) inhibition. In addition, co-treatment with ShancholTM and butyrate synergistically increased the secretion of adenosine triphosphate (ATP). Moreover, CCL20 secretion was decreased by inhibiting the extracellular ATP receptor P2X7. However, neither inflammasomes nor caspases were involved in CCL20 production. The culture supernatant of cells treated with ShancholTM and butyrate augmented human immature dendritic cell migration. Collectively, these results suggest that butyrate enhances ShancholTM-induced CCL20 production in human intestinal epithelial cells via HDAC inhibition and ATP-P2X7 signaling by activating GPR109A. These effects potentially enhance the mucosal immune responses in the gut induced by this oral cholera vaccine.
KW - Butyrate
KW - Chemokines
KW - Cholera vaccine
KW - Intestinal epithelial cells
KW - Short-chain fatty acids
UR - http://www.scopus.com/inward/record.url?scp=85041103113&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2018.00055
DO - 10.3389/fimmu.2018.00055
M3 - Article
AN - SCOPUS:85041103113
SN - 1664-3224
VL - 9
JO - Frontiers in Immunology
JF - Frontiers in Immunology
IS - JAN
M1 - 55
ER -